ArticleFrontiers in oncology2026

Integration of multiparametric MRI and clinical indicators to predict response to immune-targeted therapy in patients with advanced hepatocellular carcinoma.

Shuai Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.